AxioNovo GmbH (secondary packaging; batch release)

Ukraine

All drugs from this manufacturer

  • BENDAMUSTINE AXIOS

    The drug is used for the therapy of chronic lymphocytic leukemia, indolent non-Hodgkin lymphomas, as well as multiple myeloma (in patients aged 65 and older who are not candidates for stem cell transplantation).

    Dosage form: powder for concentrate for infusion solution

    Active substance Dosage
    bendamustine 25 mg or 100 mg

    ATC: L01AA09